Results 151 to 160 of about 8,174 (197)

Analysis of the susceptibility of refractory hepatitis C virus resistant to nonstructural 5A inhibitors. [PDF]

Sci Rep
Toyodome A, Mawatari S, Eguchi H, Takeda M, Kumagai K, Taniyama O, Ijuin S, Sakae H, Tabu K, Oda K, Ikeda M, Ido A.   +11 more
europepmc   +1 more source

Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India. [PDF]

BMC Infect Dis
Bakshi S, Dutta S, Biswas A, Das R, Nath S, Ghosh A, Baskey U, Sadhukhan PC.   +7 more
europepmc   +1 more source

Efficacy of Direct Acting Antivirals (DAA) therapy in patients with recurrent hepatitis C after liver and kidney transplantation: a cross-sectional study. [PDF]

Front Med (Lausanne)
Kashani M, Karimi M, Sharifi Rayeni A, Azizi Nadian MA, Mortezazadeh M, Parsaei A, Abolghasemi N, Shirsalimi N, Mofidi A, Seyyed Mahmoudi ST.   +9 more
europepmc   +1 more source

A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs). [PDF]

Viruses
Di Marco L, Cannova S, Ferrigno E, Landro G, Nonni R, Mantia C, Cartabellotta F, Calvaruso V, Di Marco V.   +8 more
europepmc   +1 more source

A Bibliometric Analysis of the HCV Drug-Resistant Majority and Minority Variants. [PDF]

Int J Environ Res Public Health
Immanuel OM, Fabiyi OT, Oshakbayev KP, Abuova G, Konysbekova A, Vattipally SB, Ali S, Abidi SH.   +7 more
europepmc   +1 more source

Understanding the cascade of care and predictors of treatment success among patients with hepatitis C - A prospective study at a tertiary care center in India. [PDF]

IJID Reg
Rai SK, Oberoi S, Singh A, Singh H.
europepmc   +1 more source

Cause-specific mortality following sustained virologic response in hepatitis C patients treated with direct-acting antivirals: a standardized mortality ratio analysis. [PDF]

Sci Rep
Mawatari S, Tanoue S, Kumagai K, Oda K, Toyodome A, Sakae H, Fujisaki K, Inada Y, Uto H, Saisyoji A, Hiramine Y, Tabu K, Ijuin S, Hori T, Tamai T, Moriuchi A, Kanmura S, Ido A.   +17 more
europepmc   +1 more source

An unusual survival for 6.5 years with end-stage hepatitis C related advanced liver cirrhosis following sustained virologic response with direct antiviral agents - A case report from A low-resource setting. [PDF]

Niger Med J
Stephen RI, Reyes JA, Dunga JA, Awang SK, Zawaya KP.   +4 more
europepmc   +1 more source

Impact of Direct-Acting Antivirals on Extrahepatic Manifestations in Chronic Hepatitis C: A Narrative Review with a Hermeneutic Approach. [PDF]

Healthcare (Basel)
Balta AAS, Ignat MD, Barbu RE, Dumitru C, Radaschin DS, Bulza V, Mateescu Costin SA, Pleșea-Condratovici C, Baroiu L.   +8 more
europepmc   +1 more source

Outcomes of Direct-Acting Antivirals Versus Interferon-Based Therapy in Chronic Hepatitis C Infection.

Cureus
Chowdhury R, Rashid W, Singh T, Rehman A, Daterdiwala NF, Mkosi V, Limbu B, Bukhari SA, Ramadhan A, Dabas MM, Shehryar A, Khan R.   +11 more
europepmc   +1 more source